High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth.
Zhihua WangMiaomiao WangMengxin ZhangKaikun XuXinshuai ZhangYi XieYiming ZhangCheng ChangXiaolu LiAihua SunFuchu HePublished in: BMC medicine (2022)
Taken together, we reported several high-affinity SOAT1 ligands and demonstrated their clinical potential in the precision therapy of liver cancer, and also reveal the potential antitumor mechanism of SOAT1-targeting compounds.